Related Experiment Video
Updated: Aug 8, 2026
Genome-wide Protein-protein Interaction Screening by Protein-fragment Complementation Assay (PCA) in Living Cells
Published on: March 3, 2015
Protein-fragment complementation assays (PCA) in small GTPase research and drug discovery
John K Westwick1, Stephen W Michnick
1Canada Research Chair in Integrative Genomics, Département de Biochimie, Université de Montreal, Canada.
Abstract:
Small GTPases of the Ras and Rho families are among the most studied signaling proteins and represent promising therapeutic targets for human neoplastic disease. Despite the high level of interest in these proteins, direct analysis of most aspects of Ras protein biology in living cells has not been possible, because much of the details of Ras signaling cannot be studied in vitro but requires simple cell-based assays. Here we describe a strategy for directly analyzing Ras signaling pathways in living cells using protein-fragment complementation assays (PCA) based on fragments of intensely fluorescent proteins. The assays allow for spatial and temporal analysis of protein complexes including those that form upstream and downstream from Ras proteins, as well as complexes of Ras proteins with regulator and effector proteins. We describe high-throughput quantitative microscopic methods to follow temporal changes in complex subcellular location and quantity (high-content assays). Spatial and temporal changes in response to perturbations (chemical, siRNA, hormones) allow for delineation of Ras signaling networks and a general and high-throughput approach to identify drugs that act directly or indirectly on Ras pathways.
Insights
Researchers developed a new method to study Ras signaling pathways in living cells. This protein-fragment complementation assay (PCA) enables high-throughput analysis of protein interactions, aiding in drug discovery for cancer.
Area of Science:
- Molecular Biology
- Cellular Signaling
- Biochemistry
Background:
- Small GTPases, including Ras and Rho families, are crucial in cell signaling and are implicated in cancer development.
- Studying Ras protein biology in living cells is essential but challenging due to limitations in in vitro analysis.
- Existing methods often fail to capture the dynamic and complex nature of Ras signaling networks within their cellular context.
Purpose of the Study:
- To develop a novel strategy for the direct, real-time analysis of Ras signaling pathways in living cells.
- To enable spatial and temporal monitoring of protein complex formation and dynamics within Ras signaling networks.
- To establish a high-throughput platform for identifying therapeutic compounds targeting Ras pathways.
Main Methods:
- Utilized protein-fragment complementation assays (PCA) employing fragments of fluorescent proteins to detect protein interactions.
- Developed high-content, quantitative microscopic methods for temporal and spatial analysis of protein complex location and quantity.
- Applied perturbations such as chemical treatments, siRNA, and hormone stimulation to probe signaling network responses.
Main Results:
- Successfully demonstrated the capability of PCA to analyze Ras protein complexes, including upstream and downstream interactions.
- Enabled high-throughput, quantitative monitoring of dynamic changes in protein complex localization and abundance.
- Showcased the delineation of Ras signaling networks and identification of drug targets through perturbation studies.
Conclusions:
- The developed PCA strategy provides a powerful tool for dissecting complex Ras signaling networks in living cells.
- This approach facilitates a general and high-throughput method for discovering drugs that modulate Ras pathway activity.
- The findings open new avenues for understanding and targeting neoplastic diseases driven by Ras signaling.
Related Concept Videos
02:14GTPases and their Regulation
Large G-proteins, also known...
01:24Small GTPases - Ras and Rho
Three regulatory proteins control their activity: